Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-23-000169

Chief Operating Officer gave up 1,406 shares (to pay taxes)

  • Chief Operating Officer acquired 4,062 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cittadine Andrew Chief Operating Officer 2022-12-31 Option exercise +4,062 28,300 D: show line 1 in the form
Cittadine Andrew Chief Operating Officer 2022-12-31 Shares withheld for taxes −1,406 $2.37 $3,332 26,894 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Cittadine Andrew Chief Operating Officer 2022-12-31 Option exercise · Restricted Stock Units −4,062 48,750 D: show line 3 in the form
Loading xslF345X03/rdgdoc.xml…